Summar y : We examined the effects of FK506, a specific inhibitor of calcineurin, on the binding capacity of cyclic AMP-dependent protein kinase (cAMP-DPK) in gerbils subjected to 2-h cerebral hemispheric ischemia. FK506 (0,1 mg/kg) was infused intravenously at 15 min prior to the induction of ischemia by common carotid artery occlu sion. The binding capacity of cAMP-DPK was evaluated by autoradiographic analysis of the cAMP binding, and cerebral blood flow (CBF) was measured by the [14C)
constrict systemic blood vessels as well as cerebral blood vessels. On the other hand, cAMP binding was not altered Calcineurin is a Ca2+/calmodulin-dependent pro tein phosphatase and is highly abundant in the brain (Klee et aL, 1983 (Klee et aL, , 1988 Steiner et aL, 1992; Dawson et aL, 1994) . Studies have demonstrated multiple roles for calcineurin in diverse signal transduction cascades of excitable cells (Klee et aL, 1988) . This enzyme is the only known protein phosphatase that is under the direct control of intracellular Ca2+ (Gue rini et aL, 1990) and can be activated by the elevation of the intracellular Ca2+ levels that occurs under isch emic conditions, by FK506 in the sham-operated gerbils, In the ischemia group of gerbils, FK506 prevented any significant reduction of cAMP binding in the hippocampus CAl and cerebral cortices on the ischemic side, whereas it exerted no signifi cant influence on the cAMP binding of the nonischemic side. The values of CBF were comparable between the vehicle-treated gerbils and FK506-treated gerbils in the ischemic regions. Preservation of cAMP binding indicates that intracellular signal transduction via cAMP-DPK can be maintained by FK506 despite ischemia, suggesting that this agent may be beneficial for reducing ischemic tissue damage. Ke y Words: FK506-Cerebral ischemia-Cyclic AMP-Protein kinase-Calcineurin, On the other hand, cyclic AMP (cAMP) plays an important role as one of the cardinal intracellular signaling systems in the central nervous system (Blitzer et aL, 1995) , cAMP binds to the regulatory subunit of cAMP-dependent protein kinase (cAMP DPK), and the cAMP-DPK then promotes phosphor ylation of various substrates, On the other hand, cal cineurin dephosphorylates the substrates, including cAMP-DPK itself, so a close functional relationship between calcineurin and cAMP-DPK has been ob served (Klee et at, 1983; Guerini et aL, 1990; Baukal et aL, Antoni et aL, 1995; Blitzer et aL, 1995; Coghlan et aL, 1995) .
We found previously that cAMP binding was sig nificantly reduced in various regions after 2 h of cere bral ischemia (Tanaka et aL, 1995) , suggesting that the intracellular signal transduction via cAMP-DPK may be seriously compromised in ischemia, Our re cent experiments demonstrated that this reduction closely reflected early ischemic neuronal damage and was especially prominent in vulnerable regions such as the hippocampus CAl (Tanaka et aL, 1996) .
FK506 has been shown to be neuroprotective against glutamate toxicity (Dawson et aI., 1993) , focal cerebral ischemia (Sharkey and Butcher, 1994) , and transient global ischemia (Ide et aI., 1996; Tokime et aI., 1996) . Such neuroprotective effects of FK506 are considered to be due mainly to inhibition of calcine urin, since FK506 is a selective inhibitor of calcine urin, when FK506 binds to endogenous FK506binding proteins (FKBPs) (Liu et aI., 1991; Mukai et aI., 1993; Kissinger et aI., 1995) . FKBPs are highly concentrated in discrete neuronal sites, including the hippocampus CAl (Steiner et aI., 1992; Dawson et aI., 1994) . Colocalization of FKBPs and calcineurin has also been demonstrated in the brain (Steiner et aI., 1992; Dawson et aI., 1994) .
Based on these considerations, the present study was undertaken to examine whether neuroprotective effects of FK506 can be observed from the standpoint of cAMP-DPK during cerebral ischemia. We there fore assessed the effects of FK506 on the cAMP binding in sham-operated gerbils and in gerbils sub jected to 2-h ischemia induced by occlusion of the common carotid artery (CCAO). The autoradio graphic method employed in the present study en abled us to measure local cerebral blood flow and cAMP bindin � in the same brain (Tanaka et aI., 1991) .
MATERIALS AND METHODS

Animal preparation
The protocol described here had been approved as meet ing the Animal Experimentation Guidelines of Keio Uni versity School of Medicine. A total of 36 Mongolian gerbils of either sex, weighing 60-100 g, were divided into four groups: a vehicle + sham group (n = 6), an FK506 + sham group (n = 5), a vehicle + CCAO group (n = 16), and an FK506 + CCAO group (n = 9). In all of these groups, polyethylene catheters (Clay-Adams PE 10; Becton Dickinson, Parsippany, NJ, U.S.A.) were inserted into the femoral artery and vein under light anesthesia with pento barbital sodium (20 mg/kg, i.p.). In addition, the right CCA was exposed, and a 5-0 silk suture was loosely looped around the artery for the future ligation. The arterial blood pressure and blood gases were monitored through the arte rial catheters. After the gerbils had recovered from the anesthesia to a fully alert state at 2 h following catheteriza tion, FK506 (0.1 mg/kg, freshly dissolved in saline) was injected intravenously in the FK506 + sham and FK506 + CCAO groups, whereas vehicle (saline, 0.5 ml) was in jected in the vehicle + sham and vehicle + CCAO groups. At 15 min after the above injections, the right CCA was doubly tied with the silk suture to induce 2-h cerebral ischemia in the vehicle + CCAO and FK506 + CCAO groups under light anesthesia with 1.5% halothane. The halothane inhala tion was terminated following the ligation of the artery.
At 15 min after the ligation, the gerbils were evaluated for various neurologic signs to calculate the stroke index (McGraw, 1977; Nozaki et aI., 1996) . The gerbils that scored more than 5 for the stroke index were subjected to further study as the vehicle + CCAO group (n = 8) and the FK506 + CCAO group (n = 5). On the other hand, the CCA was merely exposed and left unoccluded in the vehicle + sham and FK506 + sham groups. The rectal temperature was monitored continuously by a digital thermometer (Shi baura Electronics) and maintained at 37 ± OSC through out the experiments by using a heating pad and lamp.
Measurement of cerebral blood flow
At 2 h after the ligation or sham surgery of the CCA, the cerebral blood flow (CBF) was measured by the [14C]_ iodoantipyrine (lAP) method as described previously (Tanaka ct aI., 1991) . At the end of CBF measurement, the gerbils were decapitated, and within 30 s their brains were quickly removed and frozen in liquid Freon 22 (Asahi Glass). Consecutive 20-p,m-thick coronal sections were pre pared on a cryostat (Cryocut 1800; Leica, Nussloch, Ger many). Double sets of sections were used for autoradio graphic measurements of the CBF and for incubation studies with [3H]cAMP, respectively. The sections assigned for CBF measurement were exposed to x-ray films (SB-5;
Eastman Kodak) together with calibrated 14C-embedded methylmethacrylate standards for 10 days.
Measurement of cAMP binding
The labeling procedure with PH]cAMP was basically similar to that described by Gundlach and Urosevic (1989) .
The cut brain sections assigned for measurement of the cAMP binding were preincubated for 20 min at 22°C in Krebs-Hepes buffer to remove endogenous cAMP and to wash out [14C]IAP completely from the brain tissue, as confirmed previously (Tanaka et aI., 1991) . Subsequently, the sections were incubated for 90 min at 22°C in buffer containing 5 nM [3H]cAMP ([5', 8-3H]cAMP ammonium salt; specific activity, 42 Ci/mmol; Amersham) and 1 mM 3-isobutyl-l-methylxanthine (IBMX; Sigma). The IBMX was included to prevent hydrolysis of [3H]cAMP by phos phodiesterase in the brain tissue (Gundlach and Urosevic, 1989) . Nonspecific binding was defined as that in the pres ence of 10 p,M unlabeled cAMP (Sigma). Autoradiograms were generated by apposing the labeled sections to tritium sensitive Ultrofilm (Leica) with calibrated 3H-embedded polymer standards (Amersham) for 3 weeks.
Data analysis
Quantitative densitometric analysis of the autoradio grams was performed with the computerized digital image processing system (Tanaka et aI., 1991) . The data obtained were tested by analysis of variance. When this procedure indicated a significant difference, the t test with the Bonfer roni correction was performed for simultaneous multiple comparisons (Wallenstein et aI., 1980) . Values are pre sented as the means ± SD. Table 1 , the physiological parameters determined immediately before CBF measurement were within the normal ranges. However, the mean arterial blood pressure (MABP) was slightly higher in the FK506 + sham group as compared to that in the vehicle + sham group with statistical significance. Similarly, the MABP in the FK506 + CCAO group tended to be slightly higher than that in the vehicle + Figure 2 shows representative color-coded autora diograms of the cAMP binding at the hippocampus level, which were obtained from the same gerbils as in Fig. 1 Figure 3 summarizes the data for the CBF and cAMP binding in the hippocampus CAL As shown in the top panel, the CBF in the FK506 + sham group was slightly lower than that in the vehicle + sham group on each side. On the other hand, both the vehicle + CCAO and FK506 + CCAO groups exhib ited a significant reduction in CBF on the right side, while these groups also demonstrated a moderate decrease in CBF on the left side. The CBF in the FK506 + CCAO group was slightly higher than that in the vehicle + CCAO group on both sides.
RESULTS
As shown in
As shown in the bottom panel of Fig. 3 , no signifi- The viewer's right is the right (operated) side of the gerbils. These images were from the same animals as in Fig. 1. cant differences in cAMP binding were noted be tween the vehicle + sham and FK506 + sham groups on each side of the hippocampus CAl. As reported previously (Tanaka et ai., 1995) , the cAMP binding on the right side of the vehicle + CCAO group exhib ited a significant reduction as compared to the oppo site side. In contrast, the cAMP binding on the right side of the FK506 + CCAO group demonstrated only a mild decrease with no statistical significance as compared to the opposite side, and its value was significantly higher than that on the right side of the vehicle + CCAO group. Figure 4 summarizes the data for the CBF and cAMP binding in the temporal cerebral cortex. As shown in the top panel, the CBF in the FK506 + sham group was slightly lower that that in the ve hicle + sham group on both sides. In the groups subjected to CCAO, the CBF was significantly re duced on the right side in both the vehicle + CCAO and FK506 + CCAO groups. It was also moderately decreased on the left side in these groups.
As shown in the bottom panel of Fig. 4 , the cAMP binding in the FK506 + sham group displayed a simi lar value to that in the vehicle + sham group on each side of the temporal cerebral cortex. On the other hand, the vehicle + CCAO group on the right side revealed a moderate but statistically significant de crease as compared to the opposite side and the right side of the vehicle + sham group. In contrast, the right side of the FK506 + CCAO group demon strated only a slight reduction in cAMP binding as compared to the opposite side, and its value was significantly higher than that on the right side of the vehicle + CCAO group. Similar results were ob tained in other cerebral cortical regions such as the frontoparietal and occipital cortices. Figure 5 summarizes the data for the CBF and cAMP binding in the cerebellar cortex. As observed in the temporal cerebral cortex, the CBF in the FK506 + sham group was slightly lower than that in the vehicle + sham group on both sides. The CBF in the vehicle + CCAO group exhibited a moderate reduction as compared to the vehicle + sham group, whereas the CBF in the FK506 + CCAO group did not undergo a definite reduction as compared to the FK506 + sham group (top panel) .
As shown in the bottom panel of Fig. 5 , the cAMP binding in the cerebellar cortex of each group dis played a similar value on both sides, and no significant differences were noted among the groups.
DISCUSSION
The present experiments revealed that (a) FK506 slightly decreased the CBF while it increased the systemic arterial blood pressure in the sham-operated gerbils, (b) the CBF in the FK506 + CCAO group was slightly higher in the nonischemic regions such (ml/100 g/min) as the left hippocampus CAl and bilateral cerebellar cortices as compared to the vehicle + CCAO group, ( C) FK506 did not exert any definite influence on the cAMP binding in the sham-operated gerbils, and (d) FK506 significantly prevented a reduction in cAMP binding in the hippocampus CAl and tempo ral cerebral cortex in the gerbils subjected to 2-h hemispheric ischemia. FK506 has been reported to increase arterial blood pressure and sympathetic activity, and such actions are apparently related to inhibition of calcineurin (Lyson et ai., 1993) . FK506 also decreases endothelial release of prostacyclin, while it increases the release of endothelin (Yatscoff et ai., 1993) . These pharma cological properties may also contribute to the in crease in arterial blood pressure induced by FK506. In fact, clinical studies have suggested that hyperten sion is an important side effect of FK506 (Armitage et ai., 1991) . In line with these reports, we found that intravenous injection of FK506 slightly increased the MABP as compared to that of the vehicle-treated groups as shown in Table 1 . These observations imply that FK506 exerts vasoconstricting actions on the sys temic vascular system. In the present study, the CBF in the FK506 + sham group was slightly decreased as compared to the vehicle + sham group. We infer that FK506 may constrict not only systemic blood vessels but also cerebral blood vessels to some degree.
Cerebral Blood Flow
J Cereb Blood Flow Melab, Vol. 17, No.4, 1997 The CBF on the nonischemic side in the FK506 + CCAO group showed a slight increase as compared to the vehicle + CCAO group in each examined region. A slight increase in MABP in the FK506 + CCAO group as compared to the vehicle + CCAO group may be responsible for the above increase in CBF, since autoregulation of CBF is known to be (milt 00 g/min) Cerebral Blood Flow (mean±SO) extensively impaired in the acute phase of severe ischemia. cAMP-DPK is a tetramer containing two regula tory subunits and two catalytic subunits. Phosphory lation of the regulatory subunit causes cAMP-DPK to dissociate readily into the regulatory subunits and active catalytic subunits. On the other hand, dephos phorylation of the regulatory subunit leads cAMP DPK to assume the inactive state with association of each subunit. Calcineurin dephosphorylates the regulatory subunit of cAMP-DPK (Klee et aI., 1983) , where cAMP-binding sites are located (Taylor et aI., 1990) . According to earlier basic studies on purified cAMP-DPK (Rangel-Aldao and Rosen, 1976) , how ever, the amounts of cAMP that can bind to the regulatory unit of cAMP-DPK were found to be iden tical for both the phosphorylated and dephosphory lated forms of cAMP-DPK, with approximately the same affinity. These pharmacological properties ap-pear to be compatible with the present data, which revealed no definite difference in cAMP binding be tween the vehicle + sham and FK506 + sham groups.
We reported previously that cAMP binding is pro gressively reduced in the hippocampus CAl and cere bral cortices at 30 min to 6 h of cerebral ischemia (Tanaka et aI., 1996) . In contrast, at 15 min of isch emia, we noted no significant reduction in cAMP binding in the brain (Tanaka et aI., 1995) . Such alter ation of cAMP binding is consistent with a progres sive decrease in cAMP-DPK activity during ischemia (Schwartz et aI., 1976) . On the other hand, according to Kobayashi et a1. (1977) , cAMP concentration in the brain increased to 13-fold greater than control at 1 min of ischemia and then declined to the level of fivefold greater than control during the late ischemic period in gerbils. Earlier investigation (Steiner et aI., 1972) also demonstrated a transient, but significant, increase in the concentration of cAMP in the brain (ml/1oo g/min) Cerebral Blood Flow CCAO, common carotid artery occlusion.
Left cerebellar cortex Right cerebellar cortex following decapitation. Therefore, the effects of en dogenous cAMP on [3H]cAMP binding should be considered. However, as already discussed (Gun dlach and Urosevic, 1989; Tanaka et aI., 1996) , the present binding protocol for [3H]cAMP can be ex pected to reduce the endogenous cAMP concentra tions to negligible levels within the tissue. Conse quently, we consider that the decrease in cAMP binding observed in our experiment is not parallel with cAMP production in the ischemic brain and not due to excessive production of cAMP. We speculate that the reduction in cAMP binding observed in the present study may have been attributed to ischemic structural damage of cAMP-DPK protein.
In the present study, administration of FK506 sig nificantly prevented the reduction of cAMP binding in the ischemic regions. Several mechanisms should be considered to explain this effect of FK506. One of them may be a maintained phosphorylation of J Cereb Blood Flow Metab, Vol. 17, No.4, 1997 cAMP-DPK due to inhibition of calcineurin by FK506. The intracellular Ca2+ level increases signifi cantly in cerebral ischemia, so calcineurin is expected to be markedly activated. As described above, de phosphorylation of cAMP-DPK may lead each sub unit of cAMP-DPK to assume the associated state forming a tetramer, and cAMP-binding sites may thus be less accessible under ischemic conditions (Taylor et aI., 1990) . As mentioned previously, however, ear lier basic studies have suggested that the binding ca pacity of cAMP-DPK may be identical for the phos phorylated and dephosphorylated forms (Rangel Aldao and Rosen, 1976) , so a direct influence of FK506 on the phosphorylation state of cAMP-DPK might not be involved in the present results.
The effect of FK506 on CBF needs some consid eration. In the hippocampus CAl on the ischemic side, the CBF was 4.3 ± 4.2 ml 100 g-l min-1 in the vehicle + CCAO group, whereas it was 8.2 ± 9.3 ml 100 g-I min-I in the FK506 + CCAO group. Accord ing to our recent research (Tanaka et aI., 1996) , the cAMP binding was similarly reduced at 2 h of isch emia in the hippocampus CAl irrespective of the value of CBF if the CBF was <20 ml-1100 g min-I. The slightly higher level of CBF in the FK506 + CCAO group may therefore not contribute to the prevention of a reduction in cAMP binding in this group. Further, the CBF in the temporal cerebral cortex in both the vehicle + CCAO and the FK506 + CCAO groups was at similar levels, so the effects of FK506 on the cAMP binding in this region cannot be explained from the standpoint of CBF.
Finally, we should evaluate the possible neuropro tective effects of FK506 against ischemic damage. Recent reports have indicated that FK506 prevents histological damage in focal cerebral ischemia (Shar key and Butcher, 1994) as well as in transient global ischemia (Ide et aI., 1996; Tokime et aI., 1996) . FK506 also attenuates glutamate neurotoxicity (Dawson et aI., 1993) . Such protective effects of FK506 may have reduced the ischemic neuronal damage in the present study so that a reduction in cAMP binding in the ischemic regions was, therefore, secondarily pre vented. Deactivation of nitric oxide synthase by inhi bition of calcineurin has been speculated to play an important r61e in the cytoprotective effects of FK506 (Dawson et aI., 1993) . Since the preservation of cAMP binding in the present study indicates that signal transduction via cAMP-DPK may be main tained despite ischemia, FK506 could be useful for supporting the tissue viability.
In conclusion, FK506, a specific inhibitor of cal cineurin, clearly prevented a reduction in cAMP binding in ischemic brain regions such as the hippo campus CAl and temporal cerebral cortex. The data obtained suggest that intracellular signal transduction via cAMP-DPK may be maintained by FK506 during ischemia, implying that this agent could be beneficial for reducing ischemic damage from the standpoint of cAMP-DPK. The precise mechanisms underlying this effect of FK506 need to be elucidated in the future. Steiner JP, Dawson TM, Fotuhi M, et al. (1992) 
